Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 1 47-1, 2003, Pages

  Chial, Heather J ^a   Camilleri, Michael ^a   Burton, Duane ^a   Thomforde, George ^a   Olden, Kevin W ^b   Stephens, Debra ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Antidepressant; Buspirone; Motility; Paroxetine; Venlafaxine

Indexed keywords

BUSPIRONE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN 1A AGONIST; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; GASTROINTESTINAL TRACT FUNCTION; GASTROINTESTINAL TRACT SCINTISCANNING; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING;

EID: 0037229534     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00266.2002     Document Type: Article

References (35)

1. Boeckxstaens GE, Hirsch DP, van den Elzen BD, Heisterkamp SH, and Tytgat GN. Impaired drinking capacity in patients with functional dyspepsia: Relationship with proximal stomach function. Gastroenterology 121: 1054-1063, 2001.
2. Bouras EP, Camilleri M, Burton D, and Thomforde G. SPECT test to measure gastric accommodation validated with simultaneous barostat measurement (Abstract). Gastroenterology 120: A398, 2001.
3. Camilleri M and Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology 103: 36-42, 1992.
4. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, and Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 36: 609-615, 1991.
5. Chial HJ, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I, and Camilleri M. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: Effects of gender, body mass index and age in health. Neurogastroenterol Motil 14: 249-253, 2002.
6. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 39: 2352-2363, 1994.
7. Cubeddu LX, Hoffmann IS, Fuenmayor NT, and Finn AL. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322: 810-816, 1990.
8. Drossman DA, Creed F, and Fava G. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterol Int 8: 47-90, 1995.
9. Gorard DA, Libby GW, and Farthing MJ. 5-Hydroxytryptamine and human small intestinal motility: Effect of inhibiting 5-hydroxytryptamine reuptake. Gut 35: 496-500, 1994.
10. Gorard DA, Libby GW, and Farthing MJ. Influence of anti-depressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 8: 159-166, 1994.
11. Gorelick AB, Koshy SS, Hooper FG, Bennett TC, Chey WE, and Hasler WL. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol Gastrointest Liver Physiol 275: G460-G466, 1998.
12. Harvey AT, Rudolph RL, and Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 57:503-509, 2000.
13. Kim DY and Camilleri M. Serotonin: A mediator of the brain-gut connection. Am J Gastroenterol 95: 2698-2709, 2000.
14. Kim DY, Delgado-Aros S, Camilleri M, Samosm M, Murray JA, O'Connor MK, Brinkmann BH, Stephens DA, Lighvani SS, and Burton DD. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 96: 3099-3105, 2001.
15. Kuiken SD, Samsom M, Camilleri M, Mullan BP, Burton DD, Kost LJ, Hardyman TJ, Brinkmann BH, and O'Connor MK. Development of a test to measure gastric accommodation in humans. Am J Physiol Gastrointest Liver Physiol 277: G1217-G1221, 1999.
16. Kuo BM, Camilleri M, Burton DD, Viramontes B, McKinzie S, Thomforde G, O'Connor MK, Brinkmann BH. Effects of 5-HT3 antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther 16: 225-233, 2001.
17. Mahmood I and Sahajwalla C. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 36: 277-287, 1999.
18. Maletta G, Mattox KM, and Dysken M. Update 2000 guidelines for prescribing psychoactive drugs. Geriatrics 55: 65-72, 75-6, 79, 2000.
19. Martinez JA and Bueno L. Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acting through 5-HT1A receptors. Eur J Pharmacol 202: 379-383, 1991.
20. Mehtonen OP, Sogaard J, Roponen P, and Behnke K. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group. J Clin Psychiatry 61: 95-100, 2000.
21. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, and Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 93: 160-165, 1998.
22. Physician's Desk Reference (54th Ed.). Montvale, NJ: Medical Economics, 2000.
23. Porter RJ, McAllister-Williams RH, and Young AH. Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers. Psychopharmacology 146: 194-198, 1999.
24. Salet GA, Samsom M, and Roelofs JM, van Berge Henegouwen GP, Smout AJ, and Akkermans LM. Responses to gastric distension in functional dyspepsia. Gut 42: 823-829, 1998.
25. Samsom M, Salet GA, Roelofs JM, Akkermans LM, van Berge Henegouwen, and Smout AJ. Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci 40: 2037-2042, 1995.
26. Sanchez C and Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19: 467-489, 1999.
27. Tack J, Piessevaux H, Coulie B, Caenepeel D, and Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115: 1346-1352, 1998.
28. Tack J, Piessevaux H, Coulie B, Fischler B, and DeGucht V. A placebo-controlled trial of buspirone, a fundus relaxing drug, in functional dyspepsia: Effect on symptoms and gastric sensory and motor function (Abstract). Gastroenterology 116: G1423, 1999.
29. Talley NJ, Phillips SF, Melton JD, Wiltgen C, and Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 111: 671-674, 1989.
30. Thumshirn M, Camilleri M, Choi MG, and Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 116: 573-585, 1999.
31. Thumshirn M, Camilleri M, Hanson RB, Schei AJ, and Kammer PP. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol Gastrointest Liver Physiol 275: G314-G321, 1998.
32. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, and Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacterpylori infection and vagal function. Gut 44: 55-64, 1999.
33. Tosetti C, Salvioli B, Stanghellini V, Cogliandro L, Cogliandro R, and Marra MG. Reproducibility of a water load test in healthy subjects and symptom profile compared to patients with functional dyspepsia (Abstract). Gastroenterology 116: A336, 1999.
34. Vassallo M, Camilleri M, Phillips SF, Brown ML, Chapman NJ, and Thomforde GM. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology 102: 102-108, 1992.
35. Von der Ohe MR, Camilleri M, Kvols LK, and Thomforde GM. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 329:1073-1078, 1993.